Disclaimer

This section gives an overview of our Company's activities in fertility. The information may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country.

US Residents should consult the EMD Serono, Inc. for information on products approved for sale in the United States of America.

Fertility
Innovation delivered simply
Fertility

Merck Serono is the world leader in fertility treatment. Our vision is to develop and market innovative, easy-to-use products to help infertile couples at every stage of the reproductive cycle: from follicular development to early pregnancy.

Merck Serono is the only drug-maker to offer recombinant versions of the three hormones used in the treatment of infertility:

  • Human follicle stimulating hormone (hFSH)
  • Human luteinizing hormone (hLH)
  • Human chorionic gonadotropin (hCG)

With a portfolio of highly effective fertility drugs, Merck Serono offers physicians the ability to tailor treatment to individual patients.

Our innovative products have helped thousands of infertile couples to realize their dream of having a child. In addition, Merck Serono pursues focused research and development in order to offer patients the fertility treatments of tomorrow.

 

More about:

        Last updated: 29/04/2008